# An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder

> **NCT00057226** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 365 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** Radafaxine

## Key facts

- **NCT ID:** NCT00057226
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2004-04
- **Final completion:** 2004-04
- **Target enrollment:** 365 (ACTUAL)
- **Last updated:** 2015-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00057226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00057226, "An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00057226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*